Search Results - Conte, Benedetta

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
    Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer

    Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer by Cattrini, Carlo, Bersanelli, Melissa, Latocca, Maria Maddalena, Conte, Benedetta, Vallome, Giacomo, Boccardo, Francesco

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Management of young women with early breast cancer

    Management of young women with early breast cancer by Poggio, Francesca, Lambertini, Matteo, Bighin, Claudia, Conte, Benedetta, Blondeaux, Eva, D'Alonzo, Alessia, Dellepiane, Chiara, Boccardo, Francesco, Del Mastro, Lucia

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Update on the Management of Breast Cancer during Pregnancy

    Update on the Management of Breast Cancer during Pregnancy by Poggio, Francesca, Tagliamento, Marco, Pirrone, Chiara, Soldato, Davide, Conte, Benedetta, Molinelli, Chiara, Cosso, Maurizio, Fregatti, Piero, Del Mastro, Lucia, Lambertini, Matteo

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis

    Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis by Poggio, Francesca, Bruzzone, Marco, Ceppi, Marcello, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco, Viglietti, Giulia, Del Mastro, Lucia, de Azambuja, Evandro, Lambertini, Matteo

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

    Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review by Poggio, Francesca, Lambertini, Matteo, Bighin, Claudia, Conte, Benedetta, Blondeaux, Eva, D’Alonzo, Alessia, Dellepiane, Chiara, Buzzatti, Giulia, Molinelli, Chiara, Boccardo, Francesco, Del Mastro, Lucia

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak

    Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak by Tagliamento, Marco, Spagnolo, Francesco, Poggio, Francesca, Soldato, Davide, Conte, Benedetta, Ruelle, Tommaso, Barisione, Emanuela, De Maria, Andrea, Del Mastro, Lucia, Di Maio, Massimo, Lambertini, Matteo

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers

    Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers by FREGATTI, PIERO, GIPPONI, MARCO, GIACCHINO, MARIA, SPARAVIGNA, MARCO, DIAZ, RAQUEL, FIORAVANTI, EMANUELA, CORNACCHIA, CHIARA, CONTE, BENEDETTA, LAMBERTINI, MATTEO, ZOPPOLI, GABRIELE, MURELLI, FEDERICA, LUISA TONI, MARIA, TERESA CALABRΟ, MARIA, ORSINO, LINA, FRIEDMAN, DANIELE

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study

    Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study by Blondeaux, Eva, Lambertini, Matteo, Michelotti, Andrea, Conte, Benedetta, Benasso, Marco, Dellepiane, Chiara, Bighin, Claudia, Pastorino, Simona, Levaggi, Alessia, Alonzo, Alessia D’, Poggio, Francesca, Buzzatti, Giulia, Molinelli, Chiara, Fregatti, Piero, Bertoglio, Sergio, Boccardo, Francesco, Del Mastro, Lucia

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)

    Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Developmen... by Dieci, Maria Vittoria, Del Mastro, Lucia, Cinquini, Michela, Montemurro, Filippo, Biganzoli, Laura, Cortesi, Laura, Zambelli, Alberto, Criscitiello, Carmen, Levaggi, Alessia, Conte, Benedetta, Calabrese, Massimo, Fiorentino, Alba, Marchiò, Caterina, Tinterri, Corrado, Fittipaldo, Veronica Andrea, Pappagallo, Giovanni, Gori, Stefania

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Frequency and spectrum of PIK3CA somatic mutations in breast cancer

    Frequency and spectrum of PIK3CA somatic mutations in breast cancer by Martínez-Sáez, Olga, Chic, Nuria, Pascual, Tomás, Adamo, Barbara, Vidal, Maria, González-Farré, Blanca, Sanfeliu, Esther, Schettini, Francesco, Conte, Benedetta, Brasó-Maristany, Fara, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Ana Belén, Martinez, Antonio, Muñoz, Montserrat, Prat, Aleix

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis

    Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis by Schettini, Francesco, Giuliano, Mario, Giudici, Fabiola, Conte, Benedetta, De Placido, Pietro, Venturini, Sergio, Rognoni, Carla, Di Leo, Angelo, Locci, Mariavittoria, Jerusalem, Guy, Del Mastro, Lucia, Puglisi, Fabio, Conte, PierFranco, De Laurentiis, Michelino, Pusztai, Lajos, Rimawi, Mothaffar F., Schiff, Rachel, Arpino, Grazia, De Placido, Sabino, Prat, Aleix, Generali, Daniele

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Independent validation of the PAM50-based Chemo-Endocrine Score (CES) in hormonal receptor positive HER2-positive breast cancer treated with neoadjuvant anti-HER2-based therapy

    Independent validation of the PAM50-based Chemo-Endocrine Score (CES) in hormonal receptor positive HER2-positive breast cancer treated with neoadjuvant anti-HER2-based therapy by Pascual, Tomás, Fernandez-Martinez, Aranzazu, Tanioka, Maki, Dieci, M. Vittoria, Pernas, Sonia, Gavila, Joaquin, Guarnieri, Valentina, Cortes, Javier, Villagrasa, Patricia, Chic, Núria, Vidal, Maria, Adamo, Barbara, Muñoz, Montserrat, Griguolo, Gaia, Llombart, Antonio, Conte, Pierfranco, Oliveira, Mafalda, Conte, Benedetta, Paré, Laia, Galvan, Patricia, Carey, Lisa A., Perou, Charles M., Prat, Aleix

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

    Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy by Martínez-Sáez, Olga, Pascual, Tomás, Brasó-Maristany, Fara, Chic, Nuria, González-Farré, Blanca, Sanfeliu, Esther, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Anna Belén, Schettini, Francesco, Conte, Benedetta, Vidal, Maria, Adamo, Barbara, Martínez, Antoni, Muñoz, Montserrat, Moreno, Reinaldo, Villagrasa, Patricia, Salvador, Fernando, Ciruelos, Eva M., Faull, Iris, Odegaard, Justin I., Prat, Aleix

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

    Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer by Schettini, Francesco, Chic, Nuria, Brasó-Maristany, Fara, Paré, Laia, Pascual, Tomás, Conte, Benedetta, Martínez-Sáez, Olga, Adamo, Barbara, Vidal, Maria, Barnadas, Esther, Fernández-Martinez, Aranzazu, González-Farre, Blanca, Sanfeliu, Esther, Cejalvo, Juan Miguel, Perrone, Giuseppe, Sabarese, Giovanna, Zalfa, Francesca, Peg, Vicente, Fasani, Roberta, Villagrasa, Patricia, Gavilá, Joaquín, Barrios, Carlos H., Lluch, Ana, Martín, Miguel, Locci, Mariavittoria, De Placido, Sabino, Prat, Aleix

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer

    Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer by Prat, Aleix, Guarneri, Valentina, Pascual, Tomás, Brasó-Maristany, Fara, Sanfeliu, Esther, Paré, Laia, Schettini, Francesco, Martínez, Débora, Jares, Pedro, Griguolo, Gaia, Dieci, Maria Vittoria, Cortés, Javier, Llombart-Cussac, Antonio, Conte, Benedetta, Marín-Aguilera, Mercedes, Chic, Nuria, Puig-Butillé, Joan Anton, Martínez, Antonio, Galván, Patricia, Tsai, Yi-Hsuan, González-Farré, Blanca, Mira, Aurea, Vivancos, Ana, Villagrasa, Patricia, Parker, Joel S., Conte, Pierfranco, Perou, Charles M.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: a systematic review and meta-analysis

    HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: a systematic review and meta-analysis by Schettini, Francesco, Pascual, Tomas, Conte, Benedetta, Chic, Nuria, Brasó-Maristany, Fara, Galván, Patricia, Martínez, Olga, Adamo, Barbara, Vidal, Maria, Muñoz, Montserrat, Fernández-Martinez, Aranzazu, Rognoni, Carla, Griguolo, Gaia, Guarneri, Valentina, Conte, Pier Franco, Locci, Mariavittoria, Brase, Jan C., Gonzalez-Farre, Blanca, Villagrasa, Patricia, De Placido, Sabino, Schiff, Rachel, Veeraraghavan, Jamunarani, Rimawi, Mothaffar F., Osborne, C. Kent, Pernas, Sonia, Perou, Charles M., Carey, Lisa A., Prat, Aleix

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Development of a multi-parameter prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

    Development of a multi-parameter prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation by Prat, Aleix, Guarneri, Valentina, Paré, Laia, Griguolo, Gaia, Pascual, Tomás, Dieci, Maria Vittoria, Chic, Núria, González-Farré, Blanca, Frassoldati, Antonio, Sanfeliu, Esther, Cejalvo, Juan Miguel, Muñoz, Montserrat, Bisagni, Giancarlo, Brasó-Maristany, Fara, Urso, Loredana, Vidal, Maria, Brandes, Alba Ariela, Adamo, Barbara, Musolino, Antonino, Miglietta, Federica, Conte, Benedetta, Oliveira, Mafalda, Saura, Cristina, Pernas, Sònia, Alarcón, Jesús, Llombart-Cussac, Antonio, Cortés, Javier, Manso, Luis, López, Rafael, Ciruelos, Eva, Schettini, Francesco, Villagrasa, Patricia, Carey, Lisa A., Perou, Charles M., Piacentini, Federico, D’Amico, Roberto, Tagliafico, Enrico, Parker, Joel. S., Conte, Pierfranco

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: